“Suicide among veterans is an urgent public health crisis, but it’s solvable if we invest in researching new treatments for pain, depression and PTSD.”
The Multidisciplinary Association for Psychedelic Studies (MAPS) has been awarded a US$12,979,050 ($16,254,183) grant to continue its investigation into the treatment of post-traumatic stress disorder (PTSD) with cannabis.
The funding will allow the non-profit research and educational organization to conduct a second randomized, controlled trial to test the therapeutic potential of cannabis as a treatment for PTSD in U.S. veterans.
– Read the entire article at Regina Leader-Post.
